Mesoblast Limited (MESO) Earnings
NASDAQ·Healthcare·Biotechnology
$15.21
-0.78%
Mkt Cap $1.99B
Next Earnings
In 126 daysWed, Sep 2, 2026
EPS Estimate
-$0.12
1 analysts
Revenue Estimate
$72.86M
Last quarter: missed by -31.22% on EPS, -3.25% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$1.99B
P/E
—
Fwd P/E
16.05
P/S
127.83
Rev TTM
—
EPS TTM
-$0.06